Company
United StatesPublic company, NYSE: PFEPfizer Inc. (NYSE: PFE), New York, NY – FDA Inspections
Inspection records and compliance data for Pfizer Inc. in New York, New York. 5 FDA inspections on record (1 OAI), last inspected July 22, 2022. Publicly traded as NYSE: PFE.
Company Profile
This profile covers Pfizer Inc. based in New York, New York, United States.
FDA Inspection History
- FDA inspections
- 5
- OAI
- 1
- VAI
- 2
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected August 10, 2009. Last inspected July 22, 2022.
Most cited issue areas
- Failure to develop written procedures2 inspections
- Failure to maintain records2 inspections
- Failure by applicant to report ADE1 inspection
FDA inspections (5)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 22, 2022 | NAI | Human Drugs · Bioresearch Monitoring | 1176364 |
| August 26, 2015 | VAI | Human Drugs · Bioresearch Monitoring | 946884 |
| October 15, 2012 | VAI | Human Drugs · Bioresearch Monitoring | 805292 |
| June 6, 2012 | NAI | Human Drugs · Bioresearch Monitoring | 785976 |
| August 10, 2009 | OAI | Human Drugs · Bioresearch Monitoring | 606526 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Pfizer Inc.
Stock ticker
PFE
Exchange
NYSE
Share price
$29.91
Market cap
$170.5B
Price as of
November 6, 2026
FEI Number
2416101
Address
235 East 42nd Street, New York, New York 10017, United States
Country
United States
ID: 76ccbd36-adc6-4041-a66b-2726d323f628